MIST
Price
$0.75
Change
-$0.05 (-6.25%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
40.02M
45 days until earnings call
OSRH
Price
$2.47
Change
+$1.00 (+68.03%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
47.61M
Ad is loading...

MIST vs OSRH

Header iconMIST vs OSRH Comparison
Open Charts MIST vs OSRHBanner chart's image
Milestone Pharmaceuticals
Price$0.75
Change-$0.05 (-6.25%)
Volume$9.82K
Capitalization40.02M
OSR Holdings
Price$2.47
Change+$1.00 (+68.03%)
Volume$60.48K
Capitalization47.61M
MIST vs OSRH Comparison Chart
Loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIST vs. OSRH commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIST is a Hold and OSRH is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MIST: $0.75 vs. OSRH: $2.47)
Brand notoriety: MIST and OSRH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIST: 99% vs. OSRH: 1610%
Market capitalization -- MIST: $40.02M vs. OSRH: $47.61M
MIST [@Biotechnology] is valued at $40.02M. OSRH’s [@Biotechnology] market capitalization is $47.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIST’s FA Score shows that 0 FA rating(s) are green whileOSRH’s FA Score has 1 green FA rating(s).

  • MIST’s FA Score: 0 green, 5 red.
  • OSRH’s FA Score: 1 green, 4 red.
According to our system of comparison, OSRH is a better buy in the long-term than MIST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIST’s TA Score shows that 4 TA indicator(s) are bullish.

  • MIST’s TA Score: 4 bullish, 5 bearish.

Price Growth

MIST (@Biotechnology) experienced а -66.67% price change this week, while OSRH (@Biotechnology) price change was -17.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

MIST is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OSRH($47.6M) has a higher market cap than MIST($40M). MIST YTD gains are higher at: -68.220 vs. OSRH (-78.578).
MISTOSRHMIST / OSRH
Capitalization40M47.6M84%
EBITDA-37.83MN/A-
Gain YTD-68.220-78.57887%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash69.7MN/A-
Total Debt54.8MN/A-
FUNDAMENTALS RATINGS
MIST: Fundamental Ratings
MIST
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MIST
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOWL0.910.04
+4.81%
Werewolf Therapeutics
BNS48.370.85
+1.79%
Bank of Nova Scotia
BNTC12.760.21
+1.67%
Benitec Biopharma
LTC35.400.08
+0.23%
LTC Properties
RMBS46.15-6.53
-12.40%
Rambus

MIST and

Correlation & Price change

A.I.dvisor tells us that MIST and AKBA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and AKBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-6.61%
AKBA - MIST
33%
Poorly correlated
-2.59%
GYRE - MIST
29%
Poorly correlated
-4.37%
PRAX - MIST
29%
Poorly correlated
-10.08%
OSRH - MIST
29%
Poorly correlated
+68.03%
ADAP - MIST
28%
Poorly correlated
+7.74%
More

OSRH and

Correlation & Price change

A.I.dvisor tells us that OSRH and MIST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSRH and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSRH
1D Price
Change %
OSRH100%
+68.03%
MIST - OSRH
29%
Poorly correlated
-6.61%
VERA - OSRH
27%
Poorly correlated
-3.52%
IFRX - OSRH
26%
Poorly correlated
-7.39%
EDIT - OSRH
24%
Poorly correlated
-4.66%
EDSA - OSRH
23%
Poorly correlated
-5.31%
More